Relay Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Entry into a Material Definitive Agreement

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

7.01,9.01

Regulation FD Disclosure

Results of Operations and Financial Condition

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

06b

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Notice of Effectiveness

Prospectus Supplement with Pricing Information

Registration (IPO) statement under Securities Act of 1933

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Bergstrom Donald A

Patel Sanjiv

Catinazzo Thomas

SB INVESTMENT ADVISERS (UK) LTD; SVF Pauling (Cayman) Ltd; SOFTBANK VISION FUND (AIV M2) L.P.

Rahmer Peter

Rahmer Peter

SVF Pauling (Cayman) Ltd

Catinazzo Thomas

Patel Sanjiv

Commodore Capital LP

PERCEPTIVE ADVISORS LLC

FMR LLC

FMR LLC

Kathiresan Sekar

Kathiresan Sekar

Catinazzo Thomas

Rahmer Peter

Bergstrom Donald A

Kathiresan Sekar

Kathiresan Sekar

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

No description available

No description available

Annual Report Scanned (Paper)

No description available

No description available

No description available

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Draft registration statement (confidential submission) (amendment)